{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:53:43Z","timestamp":1781549623115,"version":"3.54.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Early-onset Group B\n                      <jats:italic toggle=\"yes\">Streptococcus<\/jats:italic>\n                      (EOGBS) infection is a leading cause of early-onset neonatal sepsis with significant morbidity and mortality. EOGBS is preventable with the administration of intrapartum antibiotic prophylaxis (IAP), recommended in New Zealand (NZ) for laboring women with clinical risk factors for infant infection. Given that there are alternative approaches to IAP eligibility, understanding the current epidemiology of infant Group B\n                      <jats:italic toggle=\"yes\">Streptococcus<\/jats:italic>\n                      (GBS) infection in NZ is essential for optimizing prevention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective study (2012\u20132021) was conducted on all infants under 180 days old with invasive GBS infection in NZ. Clinical information from the National Collections dataset was matched to laboratory samples (GBS culture\/polymerase chain reaction positive on a sterile site). Infection timing was classified as early-onset (\u22642 days of life), late-onset (3\u201389 days) or ultra-late-onset (90\u2013179 days). GBS incidence rates were calculated using Poisson regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were 406 laboratory-confirmed and 224 clinically suspected GBS cases. Although EOGBS incidence was higher than previously described, there was no significant change in incidence over the study period (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.4). EOGBS incidence for Pacific infants was twice that of European infants, with higher rates also found for M\u0101ori infants. While no GBS isolates were resistant to penicillin or vancomycin, a third of recent EOGBS isolates were resistant to erythromycin and\/or clindamycin. The case-fatality rate was low (2.5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The NZ EOGBS prevention program is less effective than previously believed, with unexplained ethnic disparities in infection rates. Identifying gaps in prevention and considering alternative strategies is crucial to reducing infant GBS infection incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004908","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:00:18Z","timestamp":1751292018000},"page":"1209-1215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology of Infant Group B Streptococcus Infection in New Zealand: A 10-Year Retrospective Study"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-0027","authenticated-orcid":false,"given":"Jane R.","family":"Millar","sequence":"first","affiliation":[{"name":"Christchurch Hospital Paediatric Department, Health New Zealand Te Whatu Ora, Waitaha\/Canterbury, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Anglemyer","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand"},{"name":"Health Intelligence and Surveillance Team, Institute of Environmental Science and Research, Porirua, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Werno","sequence":"additional","affiliation":[{"name":"Microbiology Department, Canterbury Health Laboratories, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola C.","family":"Austin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Otago, Christchurch, New Zealand"},{"name":"Neonatal Department, Christchurch Women\u2019s Hospital, Health New Zealand Te Whatu Ora, Waitaha\/Canterbury, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Walls","sequence":"additional","affiliation":[{"name":"Christchurch Hospital Paediatric Department, Health New Zealand Te Whatu Ora, Waitaha\/Canterbury, New Zealand"},{"name":"Department of Paediatrics, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/cix653","article-title":"Group B streptococcal disease worldwide for pregnant women, stillbirths, and children: why, what, and how to undertake estimates?","volume":"65","author":"Lawn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R2-20260615","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive Group B streptococcal disease in the United States, 1999-2005.","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"R3-20260615","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset Group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance.","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R4-20260615","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2147\/IDR.S291511","article-title":"Understanding factors in Group B streptococcus late-onset disease.","volume":"14","author":"Berardi","year":"2021","journal-title":"Infect Drug Resist"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12519-014-0450-8","article-title":"Late and very late onset group B Streptococcus sepsis: one and the same?","volume":"10","author":"Cantey","year":"2014","journal-title":"World J Pediatr"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet (London, England)"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R8-20260615","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization With Group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses.","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1473-3099(16)30055-X","article-title":"Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis.","volume":"16","author":"Kwatra","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R10-20260615","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajo.12378","article-title":"Early-onset neonatal group B streptococcus sepsis following national risk-based prevention guidelines.","volume":"56","author":"Darlow","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-3476(73)80524-4","article-title":"Transmission of group B streptococci among parturient women and their neonates.","volume":"83","author":"Baker","year":"1973","journal-title":"J Pediatr"},{"key":"R12-20260615","first-page":"CD007467","article-title":"Intrapartum antibiotics for known maternal Group B streptococcal colonization.","volume":"6","author":"Ohlsson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20260615","article-title":"Prevention of Group B Streptococcal Early-Onset Disease in Newborns.","year":"2022"},{"key":"R14-20260615","first-page":"1","article-title":"A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT.","volume":"26","author":"Daniels","year":"2022","journal-title":"Health Technol Assess"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/1471-0528.16085","article-title":"Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis.","volume":"127","author":"Hasperhoven","year":"2020","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"R16-20260615","article-title":"GBS3 Routine testing for group B Strep trial.","year":"2023"},{"key":"R17-20260615","article-title":"Defeating meningitis by 2030: a global road map.","year":"2021"},{"key":"R18-20260615","doi-asserted-by":"crossref","first-page":"2037350","DOI":"10.1080\/21645515.2022.2037350","article-title":"Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.","volume":"18","author":"Absalon","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"R19-20260615","first-page":"U1023","article-title":"The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party.","volume":"117","author":"Campbell","year":"2004","journal-title":"N Z Med J"},{"key":"R20-20260615","article-title":"NZDep2018 analysis of census 2018 variables.","author":"Atkinson","year":"2018"},{"key":"R21-20260615","article-title":"HISO 10001:2017 Ethnicity Data Protocols.","year":"2017"},{"key":"R22-20260615","article-title":"Births and Deaths Year Ended December 2021.","author":"Stats"},{"key":"R23-20260615","article-title":"Report on Maternity Webtool."},{"key":"R24-20260615","article-title":"New Zealand Paediatric Surveillance Unit."},{"key":"R25-20260615","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.0004-8666.2002.00182.x","article-title":"Late antenatal carriage of group B Streptococcus by New Zealand women.","volume":"42","author":"Grimwood","year":"2002","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R26-20260615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1440-1754.2002.00783.x","article-title":"Early-onset neonatal group B streptococcal infections in New Zealand 1998\u22121999.","volume":"38","author":"Grimwood","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"R27-20260615","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/INF.0000000000003881","article-title":"Neonatal Group B streptococcal infection in Australia: a case\u2013control study.","volume":"42","author":"Yanni","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R28-20260615","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5694\/j.1326-5377.1995.tb124596.x","article-title":"Early-onset group B streptococcal infections in aboriginal and non-aboriginal infants.","volume":"163","year":"1995","journal-title":"Med J Aust"},{"key":"R29-20260615","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1479-828X.2011.01302.x","article-title":"Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates.","volume":"51","author":"Clifford","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R30-20260615","article-title":"Rupture of Membranes in Pregnancy."},{"key":"R31-20260615","article-title":"Preterm pre-labour rupture of membranes - after viability (>22 weeks)."}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:01:29Z","timestamp":1781546489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004908","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}